financetom
ANTX
financetom
/
Healthcare
/
ANTX
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
AN2 Therapeutics, Inc.ANTX
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases.

It is developing epetraborole, which is in a pivotal Phase 2/3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease.

The company was incorporated in 2017 and is headquartered in Menlo Park, California.

Copyright 2023-2025 - www.financetom.com All Rights Reserved